Stocks
Health Care
regn
Regeneron Pharmaceuticals
REGN
+4.42 (+0.87%)
513.28
USD
At close at Jun 18, 20:36 UTC
Income Statement
Revenue
14.20B
Gross Profit
12.23B
Operating Income
3.99B
Pretax Income
4.98B
Net Income
4.41B
EBITDA
5.32B
EBIT
4.84B
Earnings Per Share
40.89
Balance Sheet
Cash & Cash Equivalents
2.26B
Total Debt
2.70B
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
28.47B
Book Value Per Share
258.77
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.